"Kendall South Medical Center is a diversified healthcare company conveniently located in Miami, Florida. We provide primary care physician services on an outpatient basis and are dedicated to the investigation of medications and devices under the auspices of the pharmaceutical industry. We currently have a solid network of eight Board Certified Physicians, two Registered Nurses, and six Clinical Research Coordinators."

During the past decade, Kendall South Medical Center, Inc. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 18 clinical trials were completed, i.e. on average, 225% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kendall South Medical Center, Inc." #1 sponsor was "Pfizer" with 12 trials, followed by "Vanda Pharmaceuticals" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "60 Degrees Pharmaceuticals LLC" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kendall South Medical Center, Inc." #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator and "Sunovion" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kendall South Medical Center, Inc." are "Hypercholesterolemia" (4 trials), "COVID-19" (3 trials), "Non-24-Hour Sleep-Wake Disorder" (3 trials), "Osteoarthritis" (3 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Kendall South Medical Center, Inc." in a lesser frequency.

Most popular intervention types in "Kendall South Medical Center, Inc." are "Drug" (24 trials), "Other" (6 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "placebo" (4 trials), "PF-07321332" (3 trials), "Ritonavir" (3 trials) and "tasimelteon" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kendall South Medical Center, Inc." are 26 trials for "All" genders.

Currently, there are NaN active trials in "Kendall South Medical Center, Inc.". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Kendall South Medical Center, Inc., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kendall South Medical Center, Inc., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".